Blake Wise
Chief Executive Officer at Novome Biotechnologies, Inc.
Net worth: - $ as of 2024-03-30
Profile
Blake Wise is currently the Chief Executive Officer & Director at Novome Biotechnologies, Inc. Prior to his current position, he served as the Chief Executive Officer & Director at Achaogen, Inc. from 2017 to 2019.
He also held the position of Senior Director at Genentech, Inc. and served as an Independent Director at Calithera Biosciences, Inc. Mr. Wise completed his undergraduate degree at the University of California, Santa Barbara and holds an MBA from the Haas School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-04-29 | 0 ( -.--% ) | - $ | 2024-03-30 |
Blake Wise active positions
| Companies | Position | Start |
|---|---|---|
Novome Biotechnologies, Inc.
 Novome Biotechnologies, Inc. BiotechnologyHealth Technology Novome Biotechnologies, Inc. operates as a biotechnology company focused on engineering defined activities into the human gut microbiota to treat chronic diseases. The company was founded by William DeLoache, Weston Whitaker, Liz Shepherd and Zachary Russ in 2016 and is headquartered in South San Francisco, CA. | Chief Executive Officer | 2019-11-30 |
Former positions of Blake Wise
| Companies | Position | End |
|---|---|---|
| ACHAOGEN | Chief Executive Officer | 2019-11-30 |
| CALITHERA BIOSCIENCES, INC. | Director/Board Member | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Training of Blake Wise
| University of California, Santa Barbara | Undergraduate Degree |
| Haas School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CALITHERA BIOSCIENCES, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
Novome Biotechnologies, Inc.
Novome Biotechnologies, Inc. BiotechnologyHealth Technology Novome Biotechnologies, Inc. operates as a biotechnology company focused on engineering defined activities into the human gut microbiota to treat chronic diseases. The company was founded by William DeLoache, Weston Whitaker, Liz Shepherd and Zachary Russ in 2016 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Blake Wise
